Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Rawan Alswailem, Fulwah Yahya Alqahtani, Fadilah Sfouq Aleanizy, Bahauddeen M. Alrfaei, Mohammad Badran, Qamraa Hamad Alqahtani, Hosam Gharib Abdelhady & Ibrahim Alsarra. (2022) MicroRNA-219 loaded chitosan nanoparticles for treatment of glioblastoma. Artificial Cells, Nanomedicine, and Biotechnology 50:1, pages 198-207.
Read now
Read now
Erik Ladomersky, Matthew Genet, Lijie Zhai, Galina Gritsina, Kristen L. Lauing, Rishi R. Lulla, Jason Fangusaro, Alicia Lenzen, Priya Kumthekar, Jeffrey J. Raizer, David C. Binder, C. David James & Derek A. Wainwright. (2016) Improving vaccine efficacy against malignant glioma. OncoImmunology 5:8.
Read now
Read now
David C. Binder, Andrew A. Davis & Derek A. Wainwright. (2016) Immunotherapy for cancer in the central nervous system: Current and future directions. OncoImmunology 5:2.
Read now
Read now
Sara Ferluga & Waldemar Debinski. (2014) Ephs and Ephrins in malignant gliomas. Growth Factors 32:6, pages 190-201.
Read now
Read now
Articles from other publishers (47)
Masoumeh Eliyasi Dashtaki, Zahra Moradi, Yousef Moradi, Elham Asadi Farsani & Sorayya Ghasemi. (2023) Estimating the Survival Rate in Glioblastoma Multiforme Patients who
Received a Peptide Vaccine: A Systematic Review and Meta-analysis. Current Drug Targets 24:12, pages 998-1007.
Crossref
Crossref
Aishwarya Bandla, Pramila Ghode & Nitish V. Thakor. 2023. Handbook of Neuroengineering. Handbook of Neuroengineering
3027
3054
.
Catalina Lee-Chang. (2022) Understanding the relationship between gliomas and T cells: Paving the way for effective immunotherapy. Neuro-Oncology 24:10, pages 1658-1659.
Crossref
Crossref
Xiaoxue Chen, Yihong Zhang, Qinqin Zhao, Lan Bai, Xiaoqun Chen & Zhihuan Zhou. (2022) Management of dermatologic adverse events associated with tumor treating fields in patients with glioblastoma multiforme: A 27-case series. Asia-Pacific Journal of Oncology Nursing 9:8, pages 100095.
Crossref
Crossref
Jianpan Huang, Zilin Chen, Se-Weon Park, Joseph H. C. Lai & Kannie W. Y. Chan. (2022) Molecular Imaging of Brain Tumors and Drug Delivery Using CEST MRI: Promises and Challenges. Pharmaceutics 14:2, pages 451.
Crossref
Crossref
Yutao Li, Amit Sharma, Jarek Maciaczyk & Ingo G. H. Schmidt-Wolf. (2022) Recent Development in NKT-Based Immunotherapy of Glioblastoma: From Bench to Bedside. International Journal of Molecular Sciences 23:3, pages 1311.
Crossref
Crossref
Lijie Zhai, Erik Ladomersky, Kristen L. Lauing, Lakshmi Bollu, April Bell, Miri Kim, Erik Rabin & Derek A. Wainwright. 2022. Immunotherapeutic Strategies for the Treatment of Glioma. Immunotherapeutic Strategies for the Treatment of Glioma
127
151
.
Aishwarya Bandla, Pramila Ghode & Nitish V. Thakor. 2020. Handbook of Neuroengineering. Handbook of Neuroengineering
1
28
.
Fabiane Gritzenco, Jean C. Kazmierczak, Thiago Anjos, Adriane Sperança, Maura L. B. Peixoto, Marcelo Godoi, Kauane N. B. Ledebuhr, César Augusto Brüning, Lauren L. Zamin & Benhur Godoi. (2021) Base-Free Synthesis and Synthetic Applications of Novel 3-(Organochalcogenyl)prop-2-yn-1-yl Esters: Promising Anticancer Agents. Synthesis 53:15, pages 2676-2688.
Crossref
Crossref
Asbiel Hasbum, Jaqueline Quintanilla, Juan A Amieva Jr, May-Hui Ding, Arkene Levy & Sue Anne Chew. (2021) Strategies to better treat glioblastoma: antiangiogenic agents and endothelial cell targeting agents. Future Medicinal Chemistry 13:4, pages 393-418.
Crossref
Crossref
Catalina Lee-Chang, Jason Miska, David Hou, Aida Rashidi, Peng Zhang, Rachel A. Burga, Ignacio Jusué-Torres, Ting Xiao, Victor A. Arrieta, Daniel Y. Zhang, Aurora Lopez-Rosas, Yu Han, Adam M. Sonabend, Craig M. Horbinski, Roger Stupp, Irina V. Balyasnikova & Maciej S. Lesniak. (2021) Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma. Journal of Experimental Medicine 218:1.
Crossref
Crossref
Christian E. Badr, Daniel J. Silver, Florian A. Siebzehnrubl & Loic P. Deleyrolle. (2020) Metabolic heterogeneity and adaptability in brain tumors. Cellular and Molecular Life Sciences 77:24, pages 5101-5119.
Crossref
Crossref
Yi-Ju Ho, Ju-Pi Li, Ching-Hsiang Fan, Hao-Li Liu & Chih-Kuang Yeh. (2020) Ultrasound in tumor immunotherapy: Current status and future developments. Journal of Controlled Release 323, pages 12-23.
Crossref
Crossref
Federico Cucchiara, Francesco Pasqualetti, Filippo Sean Giorgi, Romano Danesi & Guido Bocci. (2020) Epileptogenesis and oncogenesis: An antineoplastic role for antiepileptic drugs in brain tumours?. Pharmacological Research 156, pages 104786.
Crossref
Crossref
Diogo S. Pellosi, Leonardo B. Paula, Maryanne T. de Melo & Antonio C. Tedesco. (2019) Targeted and Synergic Glioblastoma Treatment: Multifunctional Nanoparticles Delivering Verteporfin as Adjuvant Therapy for Temozolomide Chemotherapy. Molecular Pharmaceutics 16:3, pages 1009-1024.
Crossref
Crossref
Ying Wang, Peng Li, Bo Wang, Shuai Wang & Pinan Liu. (2019) Identification of myeloid-derived suppressor cells that have an immunosuppressive function in NF2 patients. Journal of Cancer Research and Clinical Oncology 145:2, pages 523-533.
Crossref
Crossref
Jorge Scutti. (2018) Importance of immune monitoring approaches and the use of immune checkpoints for the treatment of diffuse intrinsic pontine glioma: From bench to clinic and vice versa (Review). International Journal of Oncology.
Crossref
Crossref
Irina A Tarasova, Alesya V Tereshkova, Anna A Lobas, Elizaveta M Solovyeva, Alena S Sidorenko, Vladimir Gorshkov, Frank Kjeldsen, Julia A Bubis, Mark V Ivanov, Irina Y Ilina, Sergei A Moshkovskii, Peter M Chumakov & Mikhail V Gorshkov. (2017) Comparative proteomics as a tool for identifying specific alterations within interferon response pathways in human glioblastoma multiforme cells. Oncotarget 9:2, pages 1785-1802.
Crossref
Crossref
Manisha Singh, Christina Vianden, Mark J. Cantwell, Zhimin Dai, Zhilan Xiao, Meenu Sharma, Hiep Khong, Ashvin R. Jaiswal, Faisal Faak, Yared Hailemichael, L. M. E. Janssen, Uddalak Bharadwaj, Michael A. Curran, Adi Diab, Roland L. Bassett, David J. Tweardy, Patrick Hwu & Willem W. Overwijk. (2017) Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain. Nature Communications 8:1.
Crossref
Crossref
WALDEMAR DEBINSKI, WALDEMAR PRIEBE & STEPHEN B. TATTER. 2017. Glioblastoma. Glioblastoma
341
358
.
A.G.M. Mostofa, Surendra R. Punganuru, Hanumantha Rao Madala, Mohammad Al-Obaide & Kalkunte S. Srivenugopal. (2017) The Process and Regulatory Components of Inflammation in Brain Oncogenesis. Biomolecules 7:4, pages 34.
Crossref
Crossref
Binbin Ma, Zebin Gao, Jiacheng Lou, Hongqiang Zhang, Zhongbo Yuan, Qiong Wu, Xinyu Li & Bo Zhang. (2017) Long non-coding RNA MEG3 contributes to cisplatin-induced apoptosis via inhibition of autophagy in human glioma cells. Molecular Medicine Reports 16:3, pages 2946-2952.
Crossref
Crossref
R.Y. Huang & D.A. Reardon. 2017. Translational Immunotherapy of Brain Tumors. Translational Immunotherapy of Brain Tumors
149
179
.
Hyangsoon Noh, Jun Yan, Sungguan Hong, Ling-Yuan Kong, Konrad Gabrusiewicz, Xueqing Xia, Amy B. Heimberger & Shulin Li. (2016) Discovery of cell surface vimentin targeting mAb for direct disruption of GBM tumor initiating cells. Oncotarget 7:44, pages 72021-72032.
Crossref
Crossref
Erik Ladomersky, Lijie Zhai, Galina Gritsina, Matthew Genet, Kristen L. Lauing, Meijing Wu, C. David James & Derek A. Wainwright. (2016) Advanced age negatively impacts survival in an experimental brain tumor model. Neuroscience Letters 630, pages 203-208.
Crossref
Crossref
Stefaan W. van Gool, Stefan Holm, Johannes Rachor, Lars Adamson, Antje Technau, Eberhard Maass, Michael C. Frühwald, Paul G. Schlegel & Matthias Eyrich. (2016) Immunotherapy in atypical teratoid-rhabdoid tumors: Data from a survey of the HGG-Immuno Group. Cytotherapy 18:9, pages 1178-1186.
Crossref
Crossref
Braden C. McFarland, Margaret P. Marks, Amber L. Rowse, Samuel C. Fehling, Magda Gerigk, Hongwei Qin & Etty N. Benveniste. (2016) Loss of SOCS3 in myeloid cells prolongs survival in a syngeneic model of glioma. Oncotarget 7:15, pages 20621-20635.
Crossref
Crossref
Seyed-Mostafa Razavi, Karen E. Lee, Benjamin E. Jin, Parvir S. Aujla, Sharareh Gholamin & Gordon Li. (2016) Immune Evasion Strategies of Glioblastoma. Frontiers in Surgery 3.
Crossref
Crossref
Patrícia Domingues, María González-Tablas, Álvaro Otero, Daniel Pascual, David Miranda, Laura Ruiz, Pablo Sousa, Juana Ciudad, Jesús María Gonçalves, María Celeste Lopes, Alberto Orfao & María Dolores Tabernero. (2016) Tumor infiltrating immune cells in gliomas and meningiomas. Brain, Behavior, and Immunity 53, pages 1-15.
Crossref
Crossref
Kênia Cristina Soares Fonseca de Magalhães, Josiane Pinto Moreira Vaz, Pollyana Anicio Magalhaes Gontijo, Gervásio Teles Cardoso de Carvalho, Paulo Pereira Christo, Renata Toscano Simões & Karla Rona da Silva. (2016) Profile of patients with brain tumors and the role of nursing care. Revista Brasileira de Enfermagem 69:1, pages 150-155.
Crossref
Crossref
Roxana Maga?a-Maldonado, Elda Georgina Ch?vez-Cortez, Nora Karen Olascoaga-Arellano, Mariana L?pez-Mej?a, Fernando Manuel Maldonado-Leal, Julio Sotelo & Benjam?n Pineda. (2016) Immunological Evasion in Glioblastoma. BioMed Research International 2016, pages 1-7.
Crossref
Crossref
Hideho Okada, Michael Weller, Raymond Huang, Gaetano Finocchiaro, Mark R Gilbert, Wolfgang Wick, Benjamin M Ellingson, Naoya Hashimoto, Ian F Pollack, Alba A Brandes, Enrico Franceschi, Christel Herold-Mende, Lakshmi Nayak, Ashok Panigrahy, Whitney B Pope, Robert Prins, John H Sampson, Patrick Y Wen & David A Reardon. (2015) Immunotherapy response assessment in neuro-oncology: a report of the RANO working group. The Lancet Oncology 16:15, pages e534-e542.
Crossref
Crossref
Jun Yan, Ling-Yuan Kong, Jiemiao Hu, Konrad Gabrusiewicz, Denada Dibra, Xueqing Xia, Amy B. Heimberger & Shulin Li. (2015) FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas. JNCI: Journal of the National Cancer Institute 107:8.
Crossref
Crossref
Baisakhi Raychaudhuri, Patricia Rayman, Pengjing Huang, Matthew Grabowski, Dolores Hambardzumyan, James H. Finke & Michael A. Vogelbaum. (2015) Myeloid derived suppressor cell infiltration of murine and human gliomas is associated with reduction of tumor infiltrating lymphocytes. Journal of Neuro-Oncology 122:2, pages 293-301.
Crossref
Crossref
Vidya Gopalakrishnan, Rong-Hua Tao, Tara Dobson, William Brugmann & Soumen Khatua. (2015) Medulloblastoma development: tumor biology informs treatment decisions. CNS Oncology 4:2, pages 79-89.
Crossref
Crossref
Raquel Ordóñez, Gabriel Gallo-Oller, Soledad Martínez-Soto, Sheila Legarra, Noémie Pata-Merci, Justine Guegan, Giselle Danglot, Alain Bernheim, Bárbara Meléndez, Juan A. Rey & Javier S. Castresana. (2014) Genome-Wide Microarray Expression and Genomic Alterations by Array-CGH Analysis in Neuroblastoma Stem-Like Cells. PLoS ONE 9:11, pages e113105.
Crossref
Crossref
John H. Rossmeisl. (2014) New Treatment Modalities for Brain Tumors in Dogs and Cats. Veterinary Clinics of North America: Small Animal Practice 44:6, pages 1013-1038.
Crossref
Crossref
Derek A. Wainwright, Alan L. Chang, Mahua Dey, Irina V. Balyasnikova, Chung Kwon Kim, Alex Tobias, Yu Cheng, Julius W. Kim, Jian Qiao, Lingjiao Zhang, Yu Han & Maciej S. Lesniak. (2014) Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors. Clinical Cancer Research 20:20, pages 5290-5301.
Crossref
Crossref
B. Thaci, C. E. Brown, E. Binello, K. Werbaneth, P. Sampath & S. Sengupta. (2014) Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy. Neuro-Oncology 16:10, pages 1304-1312.
Crossref
Crossref
L. G. dePillis, A. Eladdadi & A. E. Radunskaya. (2014) Modeling cancer-immune responses to therapy. Journal of Pharmacokinetics and Pharmacodynamics 41:5, pages 461-478.
Crossref
Crossref
Sadhak Sengupta, Bart Thaci, Andrew C. Crawford & Prakash Sampath. (2014) Interleukin-13 Receptor Alpha 2-Targeted Glioblastoma Immunotherapy. BioMed Research International 2014, pages 1-8.
Crossref
Crossref
B Thaci, A U Ahmed, I V Ulasov, D A Wainwright, P Nigam, B Auffinger, A L Tobias, Y Han, L Zhang, K-S Moon & M S Lesniak. (2014) Depletion of myeloid-derived suppressor cells during interleukin-12 immunogene therapy does not confer a survival advantage in experimental malignant glioma. Cancer Gene Therapy 21:1, pages 38-44.
Crossref
Crossref
Chiara Vasco, Alessandra Canazza, Ambra Rizzo, Adele Mossa, Elena Corsini, Antonio Silvani, Laura Fariselli, Andrea Salmaggi & Emilio Ciusani. (2013) Circulating T regulatory cells migration and phenotype in glioblastoma patients: an in vitro study. Journal of Neuro-Oncology 115:3, pages 353-363.
Crossref
Crossref
Robert A. Floyd, Hugo C. Castro Faria Neto, Guy A. Zimmerman, Kenneth Hensley & Rheal A. Towner. (2013) Nitrone-based therapeutics for neurodegenerative diseases: Their use alone or in combination with lanthionines. Free Radical Biology and Medicine 62, pages 145-156.
Crossref
Crossref
Yoann Joyard, Vadim Le Joncour, H?l?ne Castel, Ch?rif Bounana Diouf, Laurent Bischoff, Cyril Papamica?l, Vincent Levacher, Pierre Vera & Pierre Bohn. (2013) Synthesis and biological evaluation of a novel 99mTc labeled 2-nitroimidazole derivative as a potential agent for imaging tumor hypoxia. Bioorganic & Medicinal Chemistry Letters 23:13, pages 3704-3708.
Crossref
Crossref
Derek A. Wainwright, Irina V. Balyasnikova, Alan L. Chang, Atique U. Ahmed, Kyung-Sub Moon, Brenda Auffinger, Alex L. Tobias, Yu Han & Maciej S. Lesniak. (2012) IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival. Clinical Cancer Research 18:22, pages 6110-6121.
Crossref
Crossref
Sadhak Sengupta, Jaclyn Marrinan, Caroline Frishman & Prakash Sampath. (2012) Impact of Temozolomide on Immune Response during Malignant Glioma Chemotherapy. Clinical and Developmental Immunology 2012, pages 1-7.
Crossref
Crossref